Results Published From Phase I Trial on Human Neural Stem Cell Transplantation in Patients With Amyotrophic Lateral Sclerosis
Results from a recent Phase I clinical trial in patients with Amyotrophic Lateral Sclerosis (ALS) showed a safe cell therapy approach that may allow for the treatment of larger pools of patients for later-phase ALS trials. The study is published in the Journal of Translational Medicine.